Literature DB >> 9119988

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

B S Coller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9119988      PMCID： PMC507964          DOI： 10.1172/JCI119307

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

Review 1.  Platelets and thrombolytic therapy.

Authors:  B S Coller
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

2.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Adhesion of platelets to surface-bound fibrinogen under flow.

Authors:  T N Zaidi; L V McIntire; D H Farrell; P Thiagarajan
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

4.  In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X.

Authors:  S V Thiruvikraman; A Guha; J Roboz; M B Taubman; Y Nemerson; J T Fallon
Journal:  Lab Invest       Date:  1996-10       Impact factor: 5.662

Review 5.  Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

Authors:  B S Coller
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

Review 6.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.

Authors:  J Lefkovits; E F Plow; E J Topol
Journal:  N Engl J Med       Date:  1995-06-08       Impact factor: 91.245

7.  Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18.

Authors:  T G Diacovo; S J Roth; J M Buccola; D F Bainton; T A Springer
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

8.  In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time.

Authors:  T Ammar; L E Scudder; B S Coller
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

9.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 10.  Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions.

Authors:  A J Marcus; L B Safier; M J Broekman; N Islam; J H Fliessbach; K A Hajjar; W E Kaminski; E Jendraschak; R L Silverstein; C von Schacky
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249
View more
  37 in total

Review 1.  Applications of anti-platelet monitoring in catheterization laboratory.

Authors:  D Mukherjee; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  Old concepts and new developments in the study of platelet aggregation.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.

Authors:  I N Gavrilovskaya; E J Brown; M H Ginsberg; E R Mackow
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 4.  Thrombolytic therapy in acute myocardial infarction.

Authors:  U Priglinger; K Huber
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 5.  Glycoprotein receptor inhibitors in the management of acute coronary syndromes.

Authors:  Henock Saint-Jacques; And Robert A Harrington
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

6.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.

Authors:  Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-Huai Wang; Timothy A Springer
Journal:  Nature       Date:  2004-09-19       Impact factor: 49.962

Review 7.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

8.  Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.

Authors:  Todd Golden; Sehem Ghazala; Rita Wadeea; Shilpa Junna
Journal:  BMJ Case Rep       Date:  2017-07-14

9.  Anucleate platelets generate progeny.

Authors:  Hansjörg Schwertz; Sarah Köster; Walter H A Kahr; Noemi Michetti; Bjoern F Kraemer; David A Weitz; Robert C Blaylock; Larry W Kraiss; Andreas Greinacher; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

Review 10.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.